Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants".
Saved in:
| Title: | Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants". |
|---|---|
| Authors: | Gómez JA; Vaccine Department, GlaxoSmithKline, Buenos Aires, Argentina., Pinto TJP; Vaccine Department, GlaxoSmithKline, Rio de Janeiro, Brazil., Guevara JN; Vaccine Department, GlaxoSmithKline, Panama City, Panama., Noronha TG; Institute of Technology for Immunobiologicals of Bio-Manguinhos, FIOCRUZ, Rio de Janeiro, Brazil. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1894898. Date of Electronic Publication: 2021 May 19. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34010099 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants". – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gómez+JA%22">Gómez JA</searchLink>; Vaccine Department, GlaxoSmithKline, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Pinto+TJP%22">Pinto TJP</searchLink>; Vaccine Department, GlaxoSmithKline, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Guevara+JN%22">Guevara JN</searchLink>; Vaccine Department, GlaxoSmithKline, Panama City, Panama.<br /><searchLink fieldCode="AU" term="%22Noronha+TG%22">Noronha TG</searchLink>; Institute of Technology for Immunobiologicals of Bio-Manguinhos, FIOCRUZ, Rio de Janeiro, Brazil. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1894898. <i>Date of Electronic Publication: </i>2021 May 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34010099 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/21645515.2021.1894898 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1894898 Titles: – TitleFull: Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants". Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gómez JA – PersonEntity: Name: NameFull: Pinto TJP – PersonEntity: Name: NameFull: Guevara JN – PersonEntity: Name: NameFull: Noronha TG IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 12 Text: 2022 Dec 31 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2164-554X Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Human vaccines & immunotherapeutics Type: main |
| ResultId | 1 |
